Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The investigational drug deuruxolitinib is effective for hair regrowth in patients with alopecia areata, putting it in line to become second approved JAK inhibitor.
Patients with inflammatory rheumatic diseases often change their diets. A rheumatologist recently reviewed the data about this approach to disease management.
Black box warnings for JAK inhibitors arise from rheumatoid arthritis studies, leading one expert to question the risk-benefit relevance to dermatologic diseases, particularly in younger patients.
VEXAS syndrome mostly affects men over 50. It is genetic, but not hereditary. Read on to know more about this autoimmune condition. TheHealthSite.com
A survey of over 3800 Chicago Marathon runners found no association between arthritis risk and running history.